Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients without diabetes mellitus after coronary artery bypass grafting: a multicenter retrospective cohort study

Table 2 Univariate Cox regression analyses for MACE

Variables	HR	95% CI	p-value
Age	1.03	1.01–1.05	0.001
Male	1.06	0.74–1.52	0.747
BMI	1.02	0.98–1.06	0.342
LVEF	0.18	0.04–0.75	0.018
Previous MI	1.05	0.72–1.52	0.807
Previous stroke	1.18	0.77–1.81	0.439
Previous PCI	0.92	0.54–1.56	0.751
Left main disease	1.17	0.82–1.67	0.378
Multivessel disease	2.48	1.02–6.04	0.046
Current smoking	1.20	0.87–1.66	0.272
Current drinking	1.05	0.75–1.48	0.773
FH-CAD	0.96	0.64–1.42	0.827
Hypertension	1.33	0.96–1.83	0.086
Hyperlipidemia	1.19	0.86–1.65	0.303
Duration of surgery	1.00	1.00–1.01	0.011
OPCABG	1.43	0.92–2.22	0.115
Number of grafts	0.97	0.83–1.13	0.666
Use of arterial grafts	1.06	0.50–2.26	0.878
FPG	1.19	1.09–1.29	< 0.001
TC	1.20	1.08–1.33	0.001
TG	1.41	1.19–1.68	< 0.001
LDL-C	1.15	0.98–1.35	0.083
HDL-C	1.16	0.64–2.10	0.616
eGFR	0.98	0.97–0.99	0.001
Antiplatelet drugs	0.91	0.13–6.46	0.921
Statins	0.89	0.60–1.32	0.549
EuroSCORE II	1.11	1.04–1.19	0.003
TyG index	1.97	1.49–2.61	< 0.001
TyG index (Per SD)	1.43	1.23–1.66	< 0.001

MACE major adverse cardiovascular events, MI myocardial infarction, BMI body mass index, PCI percutaneous coronary intervention, LVEF left ventricle ejection fraction, FH-CAD family history of coronary artery disease, OPCABG off-pump coronary artery bypass grafting, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol, eGFR estimated glomerular filtration rate, EuroSCORE European System for Cardiac Operative Risk Evaluation score, TyG index triglyceride-glucose index, SD standard deviation, HR Hazard ratio, CI Confidence interval
p values in bold are < 0.05

ISSN: 1475-2840